Adecoagro S.A. (AGRO)

Longboard Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts that cover Longboard Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $11.48, which forecasts a 30.31% increase in the stock price over the next year. The lowest target is $9.50 and the highest is $14.5.

Price Target: $11.48 (+30.31%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$9.50	$11.48	$12	$14.5
Change	+7.83%	+30.31%	+36.21%	+64.59%

Analyst Ratings

The average analyst rating for Longboard Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	3	3	2	2	2	2
Sell	0	0	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Javier Martinez Morgan Stanley	Morgan Stanley	Sell Maintains $10 → $9.5	Sell	Maintains	$10 → $9.5	+7.83%	Jul 16, 2025
Matheus Enfeldt UBS	UBS	Hold Maintains $11 → $9.9	Hold	Maintains	$11 → $9.9	+12.37%	Apr 29, 2025
Javier Martinez Morgan Stanley	Morgan Stanley	Hold → Sell Downgrades $13 → $10	Hold → Sell	Downgrades	$13 → $10	+13.51%	Apr 28, 2025
Matheus Enfeldt UBS	UBS	Hold Maintains $12 → $11	Hold	Maintains	$12 → $11	+19.18%	Jan 16, 2025
Matheus Enfeldt UBS	UBS	Hold Initiates $12	Hold	Initiates	$12	+36.21%	Oct 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.51B

Decreased by -0.59%

from 1.52B

Revenue Next Year

1.53B

Increased by 1.26%

from 1.51B

EPS This Year

0.65

Decreased by -27.71%

from 0.90

EPS Next Year

0.78

Increased by 19.69%

from 0.65

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	817.76M	1.12B	1.35B	1.30B	1.52B	1.51B	1.53B	1.50B
Revenue Growth	-7.82%	37.49%	19.87%	-3.63%	16.94%	-0.59%	1.26%	-2.09%
EPS	0.00	1.13	0.98	2.11	0.90	0.65	0.78	0.87
EPS Growth	-	37,566.67%	-13.36%	115.02%	-57.44%	-27.71%	19.69%	11.84%
Forward PE	-	-	-	-	-	13.60	11.36	10.16
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.8B	1.9B	1.6B
Avg	1.5B	1.5B	1.5B
Low	1.3B	1.3B	1.4B

Revenue Growth

Revenue Growth	2025	2026	2027
High	18.2%	23.8%	5.5%
Avg	-0.6%	1.3%	-2.1%
Low	-13.0%	-12.2%	-10.1%

EPS Forecast

EPS	2025	2026	2027
High	0.68	0.80	1.02
Avg	0.65	0.78	0.87
Low	0.61	0.74	0.72

EPS Growth

EPS Growth	2025	2026	2027
High	-23.8%	23.2%	31.4%
Avg	-27.7%	19.7%	11.8%
Low	-32.2%	15.0%	-7.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.